<DOC>
	<DOCNO>NCT02654444</DOCNO>
	<brief_summary>The purpose study identification quantification protein expression level breast cancer tissue . The imaging system intend diagnostic use aid pathologist detection , count classify her2 immunohistochemical ( IHC ) stain sample .</brief_summary>
	<brief_title>Semi-Quantification Her2/Neu Protein Expression Formalin Fixed , Paraffin-Embedded Normal Neoplastic Tissue</brief_title>
	<detailed_description>The anti Her2/neu Kit semi-quantitative immunohistochemical ( IHC ) assay identify Human Epithelial growth factor receptor ( Her2/neu ) expression formalin-fixed , paraffin-embedded human breast cancer tissue specimen . Results Her-2 test indicate aid assessment patient HERCEPTINÂ® ( Trastuzumab ) treatment consider . While Her-2 kit provide antibody offer direct visualization semi-quantification HER2 protein expression brightfield microscope , GenASIs GoPath system design complement routine workflow pathologist review immunohistochemically stain histologic slide .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Women breast cancer age 21 Borders tumor nuclei distinguishable Nuclei good integrity Background contain particle interfere analysis Slides analyze manually Pathologist</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Immunohistochemical ( IHC )</keyword>
	<keyword>Her2/Neu</keyword>
	<keyword>Breast cancer</keyword>
</DOC>